CASI Pharmaceuticals Inc (CASI)
5.74
+0.19
(+3.42%)
USD |
NASDAQ |
Nov 14, 16:00
5.89
+0.15
(+2.61%)
After-Hours: 17:55
CASI Pharmaceuticals Total Liabilities (Quarterly): 42.25M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 42.25M |
| March 31, 2024 | 42.54M |
| December 31, 2023 | 51.10M |
| September 30, 2023 | 23.79M |
| June 30, 2023 | 24.03M |
| March 31, 2023 | 26.17M |
| December 31, 2022 | 29.30M |
| September 30, 2022 | 44.69M |
| June 30, 2022 | 29.25M |
| March 31, 2022 | 30.85M |
| December 31, 2021 | 30.34M |
| September 30, 2021 | 26.76M |
| June 30, 2021 | 27.03M |
| March 31, 2021 | 25.90M |
| December 31, 2020 | 24.16M |
| September 30, 2020 | 21.44M |
| June 30, 2020 | 7.156M |
| March 31, 2020 | 8.245M |
| December 31, 2019 | 8.966M |
| September 30, 2019 | 8.24M |
| June 30, 2019 | 7.816M |
| March 31, 2019 | 6.847M |
| December 31, 2018 | 3.947M |
| September 30, 2018 | 6.987M |
| June 30, 2018 | 4.189M |
| Date | Value |
|---|---|
| March 31, 2018 | 3.543M |
| December 31, 2017 | 6.561M |
| September 30, 2017 | 7.138M |
| June 30, 2017 | 7.107M |
| March 31, 2017 | 6.942M |
| December 31, 2016 | 6.929M |
| September 30, 2016 | 8.734M |
| June 30, 2016 | 8.944M |
| March 31, 2016 | 9.888M |
| December 31, 2015 | 11.91M |
| September 30, 2015 | 11.83M |
| June 30, 2015 | 12.03M |
| March 31, 2015 | 12.01M |
| December 31, 2014 | 11.73M |
| September 30, 2014 | 11.57M |
| June 30, 2014 | 0.7433M |
| March 31, 2014 | 0.7559M |
| December 31, 2013 | 0.5652M |
| September 30, 2013 | 0.5014M |
| June 30, 2013 | 0.7497M |
| March 31, 2013 | 0.7946M |
| December 31, 2012 | 0.7428M |
| September 30, 2012 | 0.7261M |
| June 30, 2012 | 0.9448M |
| March 31, 2012 | 9.582M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.156M
Minimum
Jun 2020
51.10M
Maximum
Dec 2023
27.58M
Average
26.76M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.390B |
| Zai Lab Ltd | 283.19M |
| China SXT Pharmaceuticals Inc | 9.197M |
| Adagene Inc | 44.19M |
| LakeShore Biopharma Co Ltd | 144.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.27M |
| Shareholders Equity (Quarterly) | 9.021M |
| Debt to Equity Ratio | 2.047 |
| Current Ratio | 3.882 |
| Net Debt Paydown Yield | -4.65% |